Cargando…

TERT promoter mutations in primary and secondary WHO grade III meningioma

Purpose: TERT promoter mutation (TERTp(Mut)) has a strong association to recurrence and has been suggested to act as a driver mutation for malignant transformation of WHO grade I and II meningiomas. TERTp(Mut) has been investigated in selected high‐grade meningioma samples. The existence of TERTp(Mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maier, Andrea Daniela, Stenman, Adam, Svahn, Fredrika, Mirian, Christian, Bartek, Jiri, Juhler, Marianne, Zedenius, Jan, Broholm, Helle, Mathiesen, Tiit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018144/ https://www.ncbi.nlm.nih.gov/pubmed/32805769 http://dx.doi.org/10.1111/bpa.12892

Ejemplares similares

Mitotic and Proliferative Indices in WHO Grade III Meningioma
por: Daniela Maier, Andrea, et al.
Publicado: (2020)

OTEH-3. Targeted Gene-Expression analysis during malignant transformation in primary and secondary malignant meningioma
por: Maier, Andrea Daniela, et al.
Publicado: (2021)

Ten-year follow-up after Gamma Knife radiosurgery of meningioma and review of the literature
por: Lippitz, Bodo E., et al.
Publicado: (2020)

Radiation Treatment for WHO Grade II and III Meningiomas
por: Walcott, Brian P., et al.
Publicado: (2013)

Meningioma–Brain Crosstalk: A Scoping Review
por: Borch, Josefine de Stricker, et al.
Publicado: (2021)

Prompt closure versus gradual weaning of external ventricular drainage for hydrocephalus in adult patients with aneurysmal subarachnoid haemorrhage: a systematic review
por: Capion, Tenna, et al.
Publicado: (2020)

Prompt closure versus gradual weaning of extraventricular drainage for hydrocephalus in adult patients with aneurysmal subarachnoid haemorrhage: a systematic review protocol with meta-analysis and trial sequential analysis
por: Capion, Tenna, et al.
Publicado: (2019)

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
por: Juratli, Tareq A., et al.
Publicado: (2017)

Long-Term Follow-Up, Treatment Strategies, Functional Outcome, and Health-Related Quality of Life after Surgery for WHO Grade 2 and 3 Intracranial Meningiomas
por: Pettersson-Segerlind, Jenny, et al.
Publicado: (2022)

Pathologic Characteristics of Pregnancy-Related Meningiomas
por: Giraldi, Laura, et al.
Publicado: (2021)

Long-Term Follow-Up and Predictors of Functional Outcome after Surgery for Spinal Meningiomas: A Population-Based Cohort Study
por: Pettersson-Segerlind, Jenny, et al.
Publicado: (2021)

Radiomics-Based Prediction of TERT Promotor Mutations in Intracranial High-Grade Meningiomas
por: Akkurt, Burak Han, et al.
Publicado: (2023)

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)

MNG-03 PD-L1 EXPRESSION, PATIENT PROGNOSIS AND INITIAL WHO GRADE IN GRADE II/III MENINGIOMA
por: Kamamoto, Dai, et al.
Publicado: (2019)

The risk of developing a meningioma during and after pregnancy
por: Pettersson-Segerlind, Jenny, et al.
Publicado: (2021)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
por: Hellgren, L Samuel, et al.
Publicado: (2022)

Histological transformation in recurrent WHO grade I meningiomas
por: Corniola, Marco V., et al.
Publicado: (2020)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
por: Deng, Jiaojiao, et al.
Publicado: (2021)

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2013)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Posthemorrhagic Hydrocephalus in Patients with Subarachnoid Hemorrhage Occurs Independently of CSF Osmolality
por: Lolansen, Sara Diana, et al.
Publicado: (2023)

Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas
por: Mellai, Marta, et al.
Publicado: (2021)

Metastatic meningioma: Case report of a WHO grade I meningioma with liver metastases and review of the literature
por: Beutler, Bryce D., et al.
Publicado: (2019)

Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas
por: Tian, Weidong, et al.
Publicado: (2020)

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
por: Hysek, Martin, et al.
Publicado: (2019)

Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features
por: Moon, Hyung-Sik, et al.
Publicado: (2012)

Expression of Cathepsins B, D, and G in WHO Grade I Meningioma
por: Rahman, Rosanna M. A., et al.
Publicado: (2019)

Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
por: Jia, Zetian, et al.
Publicado: (2021)

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
por: Zhang, Zhen-Yu, et al.
Publicado: (2015)

Multidisciplinary management of clival chordomas; long-term clinical outcome in a single-institution consecutive series
por: Förander, Petter, et al.
Publicado: (2017)

Distinguishing grade I meningioma from higher grade meningiomas without biopsy
por: Varlotto, John, et al.
Publicado: (2015)

Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas
por: Won, So Yeon, et al.
Publicado: (2022)

Expression of Embryonic Stem Cell Markers on the Microvessels of WHO Grade I Meningioma
por: Shivapathasundram, Ganeshwaran, et al.
Publicado: (2018)

Predictors of Survival in Subtotally Resected WHO Grade I Skull Base Meningiomas
por: Da Broi, Michele, et al.
Publicado: (2021)

Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
por: Jiang, Jun, et al.
Publicado: (2023)

Surgical Outcome of Treating Grades II and III Meningiomas: A Report of 32 Cases
por: Violaris, Konstantinos, et al.
Publicado: (2013)

Health-Related Quality of Life and Return to Work after Surgery for Spinal Meningioma: A Population-Based Cohort Study
por: Pettersson-Segerlind, Jenny, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b7rcr94rrq79hofgfnovfir38n